Bentham Science Logo

Track Your Manuscript:


Current Cancer Drug Targets

Volume 21, 11 Issues, 2021
ISSN: 1873-5576 (Online)
ISSN: 1568-0096 (Print)
This journal supports open access

Contents

Current Cancer Drug Targets, Volume 21 - Number 1


Review Article

C-Myc Signaling Pathway in Treatment and Prevention of Brain Tumors

, 21(1): 2 - 20

Milad Ashrafizadeh, Ali Zarabi, Kiavash Hushmandi, Ebrahim Rahmani Moghadam, Farid Hashemi, Salman Daneshi, Fardin Hashemi, Shima Tavakol, Reza Mohammadinejad, Masoud Najafi*, Namrata Dudha and Manoj Garg*


DOI: 10.2174/1568009620666201016121005



Review Article

The Activation of Procarcinogens by CYP1A1/1B1 and Related Chemo-Preventive Agents: A Review

, 21(1): 21 - 54

Yubei Li*, Jiahua Cui and Jinping Jia*


DOI: 10.2174/1568009620666201006143419



Review Article

Tyrosine Kinase Inhibitors (TKIs) in Lung Cancer Treatment: A Comprehensive Analysis

, 21(1): 55 - 69

Sivakumar Murugesan, Jayakumar Murugesan, Seedevi Palaniappan , Sivasankar Palaniappan, Tamilselvi Murugan, Shahid S. Siddiqui and Sivakumar Loganathan*


DOI: 10.2174/1568009620666201009130008



Research Article

Tumor Penetrating Peptide-Functionalized Tenascin-C Antibody for Glioblastoma Targeting

, 21(1): 70 - 79

Prakash Lingasamy, Anett-Hildegard Laarmann and Tambet Teesalu *


DOI: 10.2174/1568009620666201001112749



Research Article

ASPM Predicts Poor Clinical Outcome and Promotes Tumorigenesis for Diffuse Large B-cell Lymphoma

, 21(1): 80 - 89

Jingjing Wu, Zhengmei He, Yaning Zhu, Chao Jiang, Yuan Deng and Bin Wei*


DOI: 10.2174/1568009620666200915090703




Editor-in-Chief

Ruiwen Zhang
Center for Drug Discovery
University of Houston
3455 Cullen Blvd.
Houston, TX 77204
(USA)
View Full Editorial Board

COPE Compliant

Cope Logo

Journal History

Current Cancer Drug Targets was launched in 2001. Dr. Ruiwen Zhang serves as the Editor-in-Chief of the journal.

Advertisement

Oct-2021-ban

Related Journals

Related eBooks

eBooks Catalog